Published in Isr J Med Sci on February 08, 1989
Chemotherapy for metastatic soft tissue sarcomas--another full circle? Br J Cancer (1991) 0.89
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer (2002) 2.34
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol (1989) 1.69
Low PSA metastatic androgen- independent prostate cancer. Eur Urol (2000) 1.20
PAGET'S DISEASE AND MALE BREAST CANCER. Isr Med Assoc J (2015) 1.08
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin. Br J Cancer (1991) 1.02
The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel. Br J Cancer (2001) 1.01
Leptomeningeal metastases--treatment results in 98 consecutive patients. Isr J Med Sci (1989) 1.01
Clinical diagnosis of secondary tumors of the heart and pericardium. Dis Chest (1969) 1.00
Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys (1999) 0.99
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol (1989) 0.98
Second neoplasms in patients with Merkel cell carcinoma. Cancer (2001) 0.98
The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer (1997) 0.96
5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage. Oncology (1989) 0.92
Therapeutic irradiation of the chest and electrocardiographic changes. Clin Radiol (1969) 0.91
Decline in pulmonary function in patients with breast cancer receiving dose-dense chemotherapy: a prospective study. Ann Oncol (2009) 0.91
A new human ovarian carcinoma cell line: establishment and analysis of tumor-associated markers. Oncology (1985) 0.90
Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer. Int J Gynecol Cancer (2001) 0.90
Phase I and clinical pharmacological evaluation of aphidicolin glycinate. J Natl Cancer Inst (1991) 0.90
[Solitary metastatic involvement of the spleen in squamous cell carcinoma of the cervix]. Harefuah (1977) 0.89
Tritiated thymidine labeling index and response in human breast cancer. J Natl Cancer Inst (1979) 0.89
Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials Group. Ann Oncol (1994) 0.88
The management of pericardial effusion in cancer patients. Chest (1977) 0.88
Correlation of erythrocyte and plasma levels of zinc, copper, and iron with evidence of metastatic spread in cancer patients. Cancer (1985) 0.87
Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial. Oncol Rep (2001) 0.87
The mechanism of human bladder tumor implantation in an in vitro model. J Urol (1986) 0.87
High-density lipoprotein and extracellular matrix promotes growth and plating efficiency of normal human mammary epithelial cells in serum-free medium. Int J Cancer (1983) 0.87
Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel. Am J Clin Oncol (1998) 0.87
Colorectal cancer in young patients in Israel: a distinct clinicopathological entity? World J Surg (2010) 0.86
Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (1995) 0.86
Isolated pericardial metastasis of parotid tumor origin. Head Neck Surg (1982) 0.85
Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512). Cancer Res (1988) 0.85
Pericardial effusion as first evidence of malignancy in bronchogenic carcinoma. J Surg Oncol (1982) 0.84
Effect of beta-blocking drug propranolol on 131 I utilization in euthyroid patients. J Clin Pharmacol New Drugs (1972) 0.84
Sex hormone binding globulin (SHBG) in breast cancer: a correlation with obesity but not with estrogen receptor status. Eur J Cancer Clin Oncol (1984) 0.83
Metastatic bone involvement in gynecological malignancies. Radiol Clin (Basel) (1978) 0.83
A sequential four-drug chemotherapy and biotherapy with interferon alpha and GM-CSF--an innovative protocol for the treatment of metastatic melanoma. Cancer Biother Radiopharm (1998) 0.83
Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers. Br J Cancer (2002) 0.83
Spontaneous pneumothorax complicating lung metastases from carcinoma of the breast. Radiol Clin (Basel) (1977) 0.83
Prognosis of patients with recurrent laryngeal carcinoma. Head Neck (2001) 0.82
Reappraisal of some dosage adjustment guidelines. Cancer Treat Rep (1987) 0.82
Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases. Br J Cancer (2001) 0.82
Combined 5-fluorouracil (5-FU) and radiation therapy following resection of locally advanced gastric carcinoma. J Surg Oncol (1986) 0.81
Parameters affecting the in vitro maturation of human monocytes to macrophages. Int J Cell Cloning (1986) 0.81
Thyroid carcinoma induced by irradiation for Hodgkin's disease. Report of a case. Acta Radiol Oncol Radiat Phys Biol (1978) 0.81
Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20). Eur J Immunol (1986) 0.81
Second primary lung carcinoma. J Surg Oncol (1980) 0.81
Breast cancer arising in surgical scars. J Surg Oncol (1976) 0.81
Familial nephritis. Isr J Med Sci (1967) 0.80
Involvement of heparanase in tumor metastasis and angiogenesis. Isr J Med Sci (1989) 0.80
Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines. Int J Oncol (1999) 0.80
Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer. Br J Cancer (2001) 0.80
The carcinomatous neuropathy. A clinical and electro-physiological comparative study, with special reference to the effect of treatment on the nervous system. Eur Neurol (1970) 0.80
Coronary artery operation in patients after breast cancer therapy. Ann Thorac Surg (1998) 0.80
Influence of propranolol on serum thyroxine in the rat. J Endocrinol (1972) 0.80
Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma. J Clin Oncol (1988) 0.79
Letter: Breast cancer arising in thoracotomy scars. Lancet (1976) 0.79
Synthesis and receptor-binding affinity of fluorotamoxifen, a possible estrogen-receptor imaging agent. J Med Chem (1985) 0.79
Aminoglutethimide-induced leukopenia: a case report and review of the literature. Oncology (1984) 0.79
Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients. Bone Marrow Transplant (2003) 0.78
Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer. Biomed Pharmacother (1988) 0.78
Comment on "Perhaps not everyone knows that...", (Ann Oncol 2001; 12: 1186). Ann Oncol (2002) 0.78
HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities. J Clin Pathol (2000) 0.78
Platelet-tumor cell interaction with the subendothelial extracellular matrix: relationship to cancer metastasis. Radiother Oncol (1985) 0.78
Antiandrogen withdrawal syndrome with cyproterone acetate. Urology (1998) 0.78
Corticosteroids in radiation-induced pericarditis. Chest (1978) 0.78
Radiation therapy for locally advanced breast cancer: prognostic factors and complication rate. Eur J Surg Oncol (1990) 0.78
The use of cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of Merkel cell carcinoma. Am J Clin Oncol (1993) 0.78
Adjuvant chemotherapy with and without radiotherapy in stage II breast cancer. Biomed Pharmacother (1988) 0.78
Detection of different interleukin-1 activities in human monocytes and monocytic cell lines. J Biol Response Mod (1986) 0.78
Second-line chemotherapy with mitoxantrone as a single agent in metastatic breast cancer. J Chemother (1993) 0.78
Growth of human mammary carcinoma cells from biopsy specimens in serum-free medium on extracellular matrix. Int J Cancer (1986) 0.78
Current concepts in cancer: ovary--treatment for stages III and IV. The multimodal approach to the treatment of stage III ovarian carcinoma. Int J Radiat Oncol Biol Phys (1982) 0.78
The treatment of advanced Merkel cell carcinoma. A multimodality chemotherapy and radiation therapy treatment approach. J Dermatol Surg Oncol (1993) 0.78
Prevention of human bladder tumor cell implantation in an in vitro assay. J Urol (1987) 0.78
Combined modality treatment for stage III ovarian carcinoma. Radiother Oncol (1985) 0.77
Enzymes of gluconeogenesis in tumor-bearing rats. Isr J Med Sci (1970) 0.77
Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary? Neoplasma (2006) 0.77
Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposide. Am J Clin Oncol (2000) 0.77
The effect of estradiol on human myelomonocytic cells. 1. Enhancement of colony formation. J Reprod Immunol (1985) 0.77
Role of radiation therapy in the management of cutaneous malignant melanoma. Am J Clin Oncol (1999) 0.77
Characterization of prolactin receptors and their distribution among American and Israeli women with breast cancer: implications for prediction of hormonal dependency and treatment. Biomed Pharmacother (1988) 0.77
The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma. Int J Radiat Oncol Biol Phys (1983) 0.77
Bronchial malignant melanoma. J Surg Oncol (1980) 0.77
The effect of estradiol on human myelomonocytic cells. II. Mechanism of enhancing activity of colony formation. J Reprod Immunol (1986) 0.77
Pleural effusion in breast cancer: influence upon clinical course and survival. Chemioterapia (1986) 0.76
Toxicity of adjuvant high-dose interferon-alpha-2b in patients with cutaneous melanoma at high risk of recurrence. Oncol Rep (1999) 0.76
Spontaneous intracranial hemorrhage in a patient with ovarian carcinoma. Gynecol Oncol (1985) 0.76
In vitro differentiation and establishment of cell lines derived from human myelomonocytic leukemia cells. Immunol Lett (1986) 0.76
Serum transcobalamin II levels in breast carcinoma patients. Isr J Med Sci (1982) 0.76
Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide. Oncology (1994) 0.76
High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second study. Oncology (1987) 0.75